BrosMed Medical was founded in 2012 and has rapidly grown into a multinational leader in intravascular interventional devices. Headquartered in the Songshan Lake High‑Tech Industrial Development Zone in Dongguan, China, the company operates five R&D centres and four manufacturing sites across China, Europe and Asia. BrosMed specialises in the research, development, production and global sales of high‑performance interventional medical devices and accessories. With more than 50 product series and over 700 product registration certificates, its portfolio spans cardiovascular and peripheral interventions, vascular access, neurovascular procedures and interventional accessories. BrosMed’s products are distributed to thousands of hospitals in more than 100 countries, and the company’s mission — “Technology Embraces Life” — reflects its commitment to dynamic, innovative and pioneering solutions.